Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.4 |
| Revenue growth | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.4 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | 0.0% |
| Research and development | 2.3 | 1.8 | 0.8 | |
| General and administrative | 4.6 | 1.4 | 0.7 | 0.6 |
| EBIT | -6.9 | -3.2 | -1.5 | -1.0 |
| EBIT margin | | | | -269.7% |
| Pre-tax income | -8.5 | -2.2 | -2.4 | -1.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -8.5 | -2.2 | -2.4 | -1.5 |
| Net margin | | | | -413.7% |
| |
| Diluted EPS | ($0.75) | ($0.35) | ($0.38) | ($0.41) |
| Shares outstanding (diluted) | 11.3 | 6.4 | 6.3 | 3.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|